PAP

Persistent Asset Partners Portfolio holdings

AUM $114M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
+$822K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
207
New
Increased
Reduced
Closed

Top Buys

1
+$4.13M
2
+$3.68M
3
+$3.58M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
THC icon
Tenet Healthcare
THC
+$2.2M

Top Sells

1
+$10.3M
2
+$4.9M
3
+$3.28M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.98M
5
CON
Concentra Group Holdings
CON
+$2.39M

Sector Composition

1 Healthcare 61.17%
2 Financials 18.93%
3 Materials 5.9%
4 Technology 3.43%
5 Energy 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
151
Gossamer Bio
GOSS
$508M
– –
-61,984
GPK icon
152
Graphic Packaging
GPK
$5.1B
– –
-8,966
IBOC icon
153
International Bancshares
IBOC
$4.11B
– –
-14,953
IMUX icon
154
Immunic
IMUX
$80.6M
– –
0
INDB icon
155
Independent Bank
INDB
$3.39B
– –
-5,382
IWM icon
156
iShares Russell 2000 ETF
IWM
$70.9B
– –
0
KALV icon
157
KalVista Pharmaceuticals
KALV
$554M
– –
-34,098
KRE icon
158
SPDR S&P Regional Banking ETF
KRE
$3.88B
– –
0
KROS icon
159
Keros Therapeutics
KROS
$447M
– –
0
LC icon
160
LendingClub
LC
$1.85B
– –
-119,628
LDI icon
161
loanDepot
LDI
$697M
– –
-122,159
LXRX icon
162
Lexicon Pharmaceuticals
LXRX
$531M
– –
0
MCK icon
163
McKesson
MCK
$97.8B
– –
-2,628
MLTX icon
164
MoonLake Immunotherapeutics
MLTX
$580M
– –
0
MNKD icon
165
MannKind Corp
MNKD
$1.68B
– –
0
MODV
166
DELISTED
ModivCare
MODV
– –
-8,757
MREO
167
Mereo BioPharma
MREO
$352M
– –
-113,247
MRNA icon
168
Moderna
MRNA
$10.9B
– –
0
NKTR icon
169
Nektar Therapeutics
NKTR
$1.07B
– –
0
NVDA icon
170
NVIDIA
NVDA
$4.47T
– –
0
NVO icon
171
Novo Nordisk
NVO
$249B
– –
-5,859
OCUL icon
172
Ocular Therapeutix
OCUL
$2.53B
– –
0
OEF icon
173
iShares S&P 100 ETF
OEF
$27.2B
– –
0
PFE icon
174
Pfizer
PFE
$140B
– –
0
PRTA icon
175
Prothena Corp
PRTA
$557M
– –
0
5 6
7
8 9